Regent Pacific Group Limited (HKG:0575)

Market Cap	134.78M
Revenue (ttm)	5.58M
Net Income (ttm)	-34.81M
Shares Out	228.44M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	347,520
Average Volume	111,777
Open	0.5200
Previous Close	0.5300
Day's Range	0.5200 - 0.6100
52-Week Range	0.3200 - 0.6800
Beta	0.77
RSI	74.90
Earnings Date	Mar 28, 2025

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiolog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD